Long COVID-19 Syndrome
13
4
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (13)
A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Inspiratory Muscle Pressure and Diaphragmatic Strength in Women With Long COVID-19: A Pressure Biofeedback-Guided Training Study
Immunoadsorption in Autoimmune Long COVID
Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
Long COVID-19 Syndrome Lifestyle Intervention Study
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients
Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).
Cognitive Function Analysis and qEEG Study in Long COVID-19 Syndrome Patients
Multimodal Long Covid19
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19
Digital Physiotherapy Practice in Long Covid-19 Patients